Nayyar Syed, MD
Medical Oncology Physician · Pittsburg, TX
Nayyar Syed, MD is a medical oncology physician with a practice address in Pittsburg, Texas, and NPI 1154411635, issued on Oct 13, 2006. Check the license (Texas N2309, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Nayyar Syed
- Credential
- MD
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License numbers
- N2309 TX
E-4626 AR
MC-2162 ID
21325 OK
Self-reported in NPPES; status is on the state search - Practice location
- 408 Quitman St Ste B, Pittsburg, TX 75686
- Phone
- (903) 708-7179
- Enumerated
- Oct 13, 2006
- Record last updated
- Nov 22, 2024
- Fax
- (903) 708-7183
- Medicaid IDs
- 158490001 AR
201742802 TX - Medicare enrollment
- Enrolled (PECOS I20090429000500); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest medical oncology physician records → All 547 in Texas → Look up another NPI →
Also registered at 408 Quitman St Ste B
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Jesi Mitchell, NPAcute Care Nurse Practitioner1639784101
Verify Nayyar Syed in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license N2309Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
3.1 times the Medicare Part D claims of the average medical oncology physician in 2024
2,188 Medicare Part D claims for 383 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. 235 claims were for opioids.
Most prescribed
- Letrozole137 claims
- Hydrocodone-Acetaminophen131 claims
- Prednisone124 claims
- Dexamethasone113 claims
- Eliquis109 claims
- Gabapentin88 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $2,199.90
106 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Texas Oncology PADallas, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Nayyar Syed among 547 medical oncology physician records in Texas
Nayyar Syed, MD is one of 547 medical oncology physician records with a practice address in Texas. 85% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 6% of them.
- NPI issued2006 · 6% of these records are older, 45% newer
- In a Medicare fileYes · 85% of these records are
- In the CMS Doctors and Clinicians fileYes · 76% of these records are
- Graduated1993 · median 2000 among the 414 with a school on file
- Record last updated2024 · 62% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
1 medical oncology physician record lists a practice address in Pittsburg
They are 1 of the 62 NPPES records with a practice address in Pittsburg, and 547 medical oncology physician records in Texas.
All 547 in Texas → Every provider in Pittsburg → Medical Oncology Physician nationwide →
The 8 medical oncology physician records with the nearest ZIP codes
- Sasha Davis, MDTyler, TX 757021194019075
- Thomas Gregory, M.D.Tyler, TX 757021174566624
- Donald Richards, MDTyler, TX 757021659313559
- Lewis Duncan, M.D.Longview, TX 756011821031253
- Larry Frase, M.D.Longview, TX 756011942242995
- Lijo John, MDLongview, TX 756011295050037
- Neeraj Sharma, MDLongview, TX 756011851334759
- Matei Socoteanu, M.D.Longview, TX 756011629269774
Common questions
What is Nayyar Syed, MD's NPI number?
Nayyar Syed, MD's National Provider Identifier (NPI) is 1154411635, issued on Oct 13, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Nayyar Syed, MD located?
The NPPES record lists a practice address at 408 Quitman St Ste B, Pittsburg, TX, 75686. Phone: (903) 708-7179. Providers update this record themselves, so call before visiting.
How can I verify Nayyar Syed, MD's license?
NPPES lists Texas license number N2309, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Nayyar Syed, MD prescribe under Medicare Part D?
In 2024, Nayyar Syed, MD had 2,188 Medicare Part D claims for 383 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.